Eupraxia Pharmaceuticals Inc.
EPRX
$2.93
-$0.175-5.65%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 71.14% | -64.72% | 61.69% | 157.76% | 5.90% |
| Total Receivables | 20.09% | 55.28% | 200.19% | 91.74% | 112.49% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 308.76% | 222.41% | 144.64% | -23.88% | 14.75% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 73.90% | -60.39% | 64.56% | 154.99% | 6.53% |
|
|
|||||
| Total Current Assets | 73.90% | -60.39% | 64.56% | 154.99% | 6.53% |
| Net Property, Plant & Equipment | -6.86% | 7.61% | -3.45% | -14.63% | -14.05% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1,071.01% | 493.55% | 4.55% | 166.67% | 176.00% |
| Total Assets | 72.42% | -59.18% | 62.51% | 149.38% | 5.98% |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | -22.14% | -12.97% | -20.12% | 209.22% | 32.77% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -99.31% | -99.31% | -44.70% | 7,107.92% | 7,952.39% |
| Total Finance Division Other Current Liabilities | -99.59% | -91.21% | 2,136.91% | 2,246.41% | 31,492.50% |
| Total Other Current Liabilities | -99.59% | -91.21% | 2,136.91% | 2,246.41% | 31,492.50% |
| Total Current Liabilities | -83.98% | -83.35% | 5.23% | 1,050.61% | 533.47% |
|
|
|||||
| Total Current Liabilities | -83.98% | -83.35% | 5.23% | 1,050.61% | 533.47% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 64.37% | 49.57% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -83.98% | -83.26% | 5.12% | 95.58% | 62.61% |
|
|
|||||
| Common Stock & APIC | 23.94% | 31.47% | 52.26% | 63.07% | 25.69% |
| Retained Earnings | -24.17% | -36.15% | -41.21% | -47.37% | -36.52% |
| Treasury Stock & Other | -53.72% | -- | -- | -- | 2.86% |
| Total Common Equity | -23.31% | -24.44% | 164.01% | 206.32% | -71.54% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -23.31% | -24.44% | 164.01% | 206.32% | -71.54% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -18.27% | -5.28% | -13.25% | -23.59% | -128.77% |
| Total Equity | 3,468.19% | -28.35% | 210.30% | 247.06% | -87.62% |
|
|
|||||
